How scoring limits the usability of minimal important differences (MIDs) as responder definition (RD): an exemplary demonstration using EORTC QLQ-C30 subscales
K Cocks, J Buchanan - Quality of Life Research, 2023 - Springer
Purpose The recommended method for establishing a meaningful threshold for individual
changes in patient-reported outcome (PRO) scores over time uses an anchor-based …
changes in patient-reported outcome (PRO) scores over time uses an anchor-based …
Microneurosurgical treatment options in peripheral nerve compression syndromes after chemotherapy and radiation treatment
EI Chang, MI Rose, K Rossi… - Journal of Surgical …, 2018 - Wiley Online Library
Chemotherapy‐induced peripheral neuropathy and radiation‐induced brachial plexopathy
are extremely debilitating conditions which can occur after treatment of malignancy …
are extremely debilitating conditions which can occur after treatment of malignancy …
[PDF][PDF] Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic …
J Mizusawa, G Ogawa, M Terada, H Ishiki, Y Kikawa… - Cureus, 2024 - cureus.com
Abstract The Setting International Standards in Analyzing Patient-Reported Outcomes and
Quality of Life Endpoints Data (SISAQOL) initiative was established in 2016 to assess the …
Quality of Life Endpoints Data (SISAQOL) initiative was established in 2016 to assess the …
[HTML][HTML] Association of change in health-related quality of life and treatment discontinuation in metastatic breast cancer: a post hoc, exploratory analysis of two …
T Kawahara, T Iwamoto, I Takashima… - Supportive Care in …, 2022 - Springer
Purpose Identifying factors associated with treatment alteration (treatment discontinuation
and dose reduction) may help to attain the treatment goals for metastatic breast cancer. The …
and dose reduction) may help to attain the treatment goals for metastatic breast cancer. The …
Prospective analysis of patient‐reported outcomes and physician‐reported outcomes with gynecologic cancer chemotherapy
T Takenaga, S Kuji, K Tanabe… - Journal of Obstetrics …, 2024 - Wiley Online Library
Objective Gynecologic cancer chemotherapy impacts the quality of life (QOL) of patients,
with lasting adverse events that may require treatment adjustments or discontinuation …
with lasting adverse events that may require treatment adjustments or discontinuation …
[HTML][HTML] Comparison of efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma: a systematic review and meta-analysis
J Chen, J Wang, T Xu - Medicine, 2019 - journals.lww.com
Background: This study aimed to compare the efficacy and safety of S-1 and capecitabine in
patients with metastatic colorectal carcinoma (mCRC). Methods: Eligible prospective clinical …
patients with metastatic colorectal carcinoma (mCRC). Methods: Eligible prospective clinical …
[HTML][HTML] Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal …
J Chen, J Wang - Medicine, 2019 - journals.lww.com
Background: We performed the present systematic review and meta-analysis to evaluate the
efficacy and safety for S-1-based regimens comparing to intravenous fluorouracil-based …
efficacy and safety for S-1-based regimens comparing to intravenous fluorouracil-based …
[HTML][HTML] 口服S-1 方案治疗转移性结直肠癌疗效与安全性的Meta 分析
赵娟娟, 雷鑫明 - 世界华人消化杂志, 2019 - wjgnet.com
口服S-1方案治疗转移性结直肠癌疗效与安全性的Meta分析 主页 简体中文 English 简体中文
登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界华人消化 …
登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界华人消化 …
[HTML][HTML] Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report
J Chen, J Wang, Y Zou - Medicine, 2021 - journals.lww.com
Interventions: The patient received gemcitabine plus cisplatin as first line treatment, and
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
Advances in chemotherapy for HER2-negative metastatic breast cancer
H Mukai, M Ito - Chinese Clinical Oncology, 2018 - cco.amegroups.org
Metastatic breast cancer cannot be curable, but significant improvement in overall survival
has been observed with the appearance of new agents. The purpose of treatment is to …
has been observed with the appearance of new agents. The purpose of treatment is to …